Story perspectives

UPS Invests $48M in Cold-Chain; FedEx Launches Life-Sciences Unit

7/25/2026

Summary

Story summary

UPS announced a $48 million investment in temperature-controlled facilities for GLP-1 drugs.
UPS posted its first $3 billion healthcare-revenue quarter in Q1 2026.
UPS President of Healthcare John Bolla warned that biologics have a tiny margin for temperature error as demand surges.
FedEx, which reported nearly $10 billion in healthcare transportation revenue for fiscal year 2026, launched a life-sciences unit in July 2026 to expand cold-chain services for pharmaceuticals.

1 of 1

Story summary

UPS announced a $48 million investment in temperature-controlled facilities for GLP-1 drugs.
UPS posted its first $3 billion healthcare-revenue quarter in Q1 2026.
UPS President of Healthcare John Bolla warned that biologics have a tiny margin for temperature error as demand surges.
FedEx, which reported nearly $10 billion in healthcare transportation revenue for fiscal year 2026, launched a life-sciences unit in July 2026 to expand cold-chain services for pharmaceuticals.